Use of levels of evidence and grades of recommendations, and aspects of the production, implementation, and timeliness of the guidelines did not differ significantly across malignancies.
The mean score did not differ between implementation clinics and control clinics.
For measures of staff awareness and capabilities, resistance from primary care, subspecialists, and support staff as a barrier to QI was uncommon, and these measures also did not differ by implementation status (p=0.20, p=0.12, and p=0.59, respectively).
Patients from the control hospitals were significantly more often women than the post-implementation PReCaP patients, but these groups did not differ in other baseline characteristics (Table 1).
Changes in the frequency of blood pressure measurement after implementation of the pay for performance initiative did not differ significantly (level change 0.85, 95% confidence interval −3.04 to 4.74, P=0.669) and trend change −0.01, 95% confidence interval −0.24 to 0.21, P=0.615).
Physical functioning, falling, and HRQoL sub-scales other than perceived health did not differ between post-implementation PReCaP patients and control patients (Tables 2 and 3).
The results of the analysis show that the creativity levels of the individuals did not differ prior to the implementation process in our study group.
Severe hyperkalemia did not differ before and after implementation of GRIP-II.
The clinical characteristics of patients with type 1 and type 2 myocardial infarction did not differ between the validation and implementation phases (data not shown).
